These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32763660)

  • 1. Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content.
    Beyazit F; Beyazit Y; Tanoglu A; Haznedaroglu IC
    Med Hypotheses; 2020 Oct; 143():110150. PubMed ID: 32763660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-Mediated Coagulopathy in COVID-19 Infection.
    Vadasz Z; Brenner B; Toubi E
    Semin Thromb Hemost; 2020 Oct; 46(7):838-840. PubMed ID: 32877959
    [No Abstract]   [Full Text] [Related]  

  • 3. Purposing Saikosaponins for the treatment of COVID-19.
    Bahbah EI; Negida A; Nabet MS
    Med Hypotheses; 2020 Jul; 140():109782. PubMed ID: 32353743
    [No Abstract]   [Full Text] [Related]  

  • 4. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
    Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.
    Horowitz NA; Brenner B
    Semin Thromb Hemost; 2020 Oct; 46(7):785-788. PubMed ID: 32785920
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19.
    Hashemi A; Madhavan MV; Bikdeli B
    Semin Thromb Hemost; 2020 Oct; 46(7):789-795. PubMed ID: 32820478
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical Ankaferd hemostat application for the management of oral cavity bleedings in children with hemorrhagic diathesis.
    Leblebisatan G; Bay A; Karakus SC; Kekilli M; Haznedaroglu IC
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):494-7. PubMed ID: 22576286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful management of bleeding after dental procedures with application of blood stopper: a single center prospective trial.
    Beyazit Y; Kart T; Kuscu A; Arslan A; Kurt M; Aktas B; Kekilli M; Haznedaroglu I
    J Contemp Dent Pract; 2011 Sep; 12(5):379-84. PubMed ID: 22269200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
    Almerie MQ; Kerrigan DD
    Med Hypotheses; 2020 Oct; 143():109883. PubMed ID: 32492562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinase-activated receptor 1: A target for repurposing in the treatment of COVID-19?
    Sriram K; Insel PA
    Br J Pharmacol; 2020 Nov; 177(21):4971-4974. PubMed ID: 32639031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone and doxycycline could be potential treatment modalities for COVID-19.
    Farouk A; Salman S
    Med Hypotheses; 2020 Jul; 140():109768. PubMed ID: 32339778
    [No Abstract]   [Full Text] [Related]  

  • 12. Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat.
    Haznedaroglu BZ; Beyazit Y; Walker SL; Haznedaroglu IC
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):21-34. PubMed ID: 22079213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible protease-activated receptor 1 downregulation mediated by Ankaferd blood stopper inducible with lipopolysaccharides inside the human umbilical vein endothelial cells.
    Karabiyik A; Güleç S; Yilmaz E; Haznedaroglu I; Akar N
    Clin Appl Thromb Hemost; 2011; 17(6):E165-70. PubMed ID: 21406410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine storm in COVID-19 and parthenolide: Preclinical evidence.
    Bahrami M; Kamalinejad M; Latifi SA; Seif F; Dadmehr M
    Phytother Res; 2020 Oct; 34(10):2429-2430. PubMed ID: 32472655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19).
    Parra-Izquierdo I; Aslan JE
    Semin Thromb Hemost; 2020 Oct; 46(7):826-830. PubMed ID: 32882716
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).
    Salamanna F; Maglio M; Landini MP; Fini M
    Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ankaferd hemostat in the management of gastrointestinal hemorrhages.
    Beyazit Y; Kekilli M; Haznedaroglu IC; Kayacetin E; Basaranoglu M
    World J Gastroenterol; 2011 Sep; 17(35):3962-70. PubMed ID: 22046083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromelain: A Review on its Potential as a Therapy for the Management of Covid-19.
    Owoyele BV; Bakare AO; Ologe MO
    Niger J Physiol Sci; 2020 Jun; 35(1):10-19. PubMed ID: 33084621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection.
    Shahzad F; Anderson D; Najafzadeh M
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.
    Ramacciotti E; Macedo AS; Biagioni RB; Caffaro RA; Lopes RD; Guerra JC; Orsi FA; Marques MA; Tafur AJ; Caprini JA; Nicolaides A; Carter CA; Filho CC; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936350. PubMed ID: 32649232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.